Lifecare Innovations Private Limited

Management

Lifecare Innovations has been jointly promoted by

Dr Jitendra N. Verma, Managing Director, Lifecare Innovations (P) Ltd.
Dr Lily Verma, Medical Director, Lifecare Innovations (P) Ltd.
Mr Iskander A. Lalljee, Director, Lifecare Innovations (P) Ltd.
Ms Arshia A. Lalljee, Director, Lifecare Innovations (P) Ltd.
Mrs. Hamida Lalljee, Director, Lifecare Innovations (P) Ltd.

Dr Jitendra N Verma, Managing Director-Academician, Scientist and Industrialist, Dr Jitendra N Verma is the Founder Managing Director of Lifecare Innovations. An MSc from Allahabad University and PhD from PGIMER, Chandigarh he has 32 years of academic and industrial research experience. Dr Verma was engaged in medical research at University of

Pennsylvania, Northwestern University, Georgetown University and Walter Reed Army Institute of Research in USA. Known for his expertise in Life Sciences & Biotechnology, Dr Verma was acclaimed for promotion of R&D and commercializing their outcome by industry-academia interactions and public-private partnerships. Dr Verma has pioneered development of NDDS based Liposomal and Nano-Drugs. As world leader in Liposome technology application for drugs, diagnostics and vaccines Dr Verma developed and Commercialized India’s first Liposomal product and world’s only liposomal diagnostic-Liposome agglutination test for Syphilis. He has contributed to Asia’s first and world’s best anti-fungal drug FUNGISOME- a Liposomal Amphotericin B. Working on malaria vaccine Dr Verma was the first to report that Liposomal vaccines elicit cellular immune response necessary for protective immunity. Dr Verma is presently involved in developing Liposomal and Nano-Drugs for treatment of Tuberculosis, Cancer, Leishmaniasis and Fungal infections. Keenly involved in translational research for taking benefits of Science & Technology by applications in everyday life Dr Verma has a number of publications, reviews and patents to his credit. He is also the recipient of numerous national, international & state awards and honors.

Dr. Lily Verma, Medical Director of the company is a medical graduate with specialization in General Surgery (MBBS, MS). She has been equally involved in both, surgical practice and medical research at eminent medical institutions. Her research areas include embryonic cell research with focus on drug mediated / cultured embryonic cells induced

recovery of spinal cord in animal models subjected to graded spinal cord injuries.Her work at Georgetown University Medical School, Washington DC pertained to drug under development as therapeutic intervention for spinal cord injuries involving extensive use of Tissue Culture Techniques, Immuno-histo-cytology and Electron Microscopic morphological assessment of recovery. She is presently engaged in evaluating a number of Controlled Release Pharmaceuticals for inclusion in Lifecare's product portfolio. Dr Verma has filed patents related to Novel Drug Delivery System.

	Prof. G. K. Khuller, Director Research -is an internationally acclaimed expert in tuberculosis and Dermatophytes. His pre-eminent position emanates from four decades of extensive work and outstanding contribution on the different facets of experimental tuberculosis, i.e. immnunodiagnostics for detection of tuberculosis, development of vaccine
against tuberculosis, sustained drug delivery system for anti-tubercular drugs, mechanism of drug resistance in mycobacteria, anti-mycobacterial peptides and pathogenesis of Dermatophytes. Prof. Khuller is former Professor & Head, Department of Biochemistry, Post Graduate Institute of Medical Education and Research, Chandigarh. Emeritus Professor of PGIMER.

Dr. Shankar M. Singh is Director (Research & Business Coordination, North America)An MSc and PhD in Organic Chemistry from Banaras Hindu University. Worked as Scientist with Malti-Chem Research Center, Baroda. Post-doctoral fellowship at Drexel University, Philadelphia to pursue research on the Antitumor agents. Joined the team of Prof.

Herbert C. Brown, Nobel Laureate, at Purdue University, Indiana and conducted studies on Organoborane Chemistry and its use in natural products’ synthesis. He has worked as Research Associate at Simon Fraser University, Canada. For over 17 years worked as Group Leader and then Director at Endorecherche Inc and Laval University Hospital Center, Quebec, Canada involving Drug Discovery and Development projects Has 18 years of extensive experience in Drug Discovery and their developments. Current R&D interests also include target selective and Control Release Drug Delivery Systems. Dr. Singh has a number of patents, articles, and communications.

Dr. Nalini Vemuri, Vice President (R & D) specializes in immunology of infectious diseases, immunodiagnostics and tissue engineering, having worked extensively in the field of mycobacterial diseases ( Tuberculosis and leprosy) for almost two decades. Dr. Vemuri has an M.Sc. degree in Biochemistry from Pune University and a Ph.D degree in Biochemistry from

P.G.I.M.E.R., Chandigarh. Based on her doctoral work in mycobacterial glycolipids she was awarded a Bronze Medal for Research Work. She pursued her research at Foundation for Medical Research, Mumbai. Under the auspices of Indo-US Senior Scientific Initiative in leprosy and a fellowship from NIH, she worked with Prof. Patrick Brennan at Colorado State University, U.S.A. She continued her research on mycobacterial diseases at National Institute of Immunology, developed a microtiter lipid ELISA tool for early diagnosis of leprosy and thereafter worked at the premier All India Institute of Medical Sciences, New Delhi. She has several publications in peer-reviewed national and international journals, reviewed manuscripts for publishers such as Oxford University Press and has presented her research work at national and international conferences.

Dr. Vemuri was earlier an Associate Professor, Biotechnology Department and Coordinator of the Pharmacy program at Jaypee Institute of Information Technology University, Noida and taught Immunology, Diagnostics & therapeutics, Cell Culture Technology, Research methodology and Diseases & Healthcare to graduate, post-graduate and Ph.D students.

Dr. Neelam Suri, Co-ordinator – Scientific Affairs is Gold Medalist M.Sc. (Hons) Biochemistry from Panjab University. She is a Ph.D. in molecular Biology from Indian Institute of Science Bangalore where she carried out her work on ‘Antibodies to mono-, di – and trinucleotides binding at specific sites on double standards stranded DNA’. She has worked in

Reproductive enzymology, Myocardial metabolism , Molecular biology and Immunology. She has been involved in research at eminent institutions like Post Graduate Institute (PGI) Chandigarh on Catecholamines, Myocardial Metabolism and Isolated Heart Perfusion. Recipient of ICAR scholarship for medical biochemistry, she has several publications to her credit. She is responsible for knowledge resource, training programs and technical support for promotion of Lifecare Products. She is also involved in the technology transfer from collaborative laboratories to the company.

	Ms. Arshia A. Lalljee, Finance Director has a Masters degree in Sociology from Jawaharlal Nehru University and M.Phil. in Business Management from Leeds University, U.K. She has rich and varied experience in Finance & Accounts Management, Banking, Corporate Affairs, Investment Management and General Administration.

	Mr. Iskander A. Lalljee, Marketing Director has rich experience in niche marketing. His expertise covers Marketing Research, Product Development and New Product Launch. Mr. Lalljee has special interest in pollution control. His efforts have also contributed in the development of eco-friendly devices aimed at minimising health hazards.

	Mrs. Hamida A. Lalljee, Director has more than 32 years industrial and administrative experience as Executive Director of Sud-Chemie India Pvt. Ltd.

	Dr. S. K. Bajpai, Vice President (Corporate Affairs)is a Ph.D. in Finance and Chartered Accountant. He carries with him more than 30 years rich experience having held senior positions in the public sector as well as the private sector. Dr. Bajpai specializes in financial planning and management, corporate plans and policies, MIS and reporting systems, risk management and capital markets.